Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old
Clinical trial NCT03199053 · COMPLETED
Trial details
- NCT number
- NCT03199053
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-11
- Primary completion
- 2023-02-01
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.